CD44v6 overexpression related to metastasis and poor prognosis of colorectal cancer: A meta-analysis

Ji-Lin Wang; Wen-Yu Su; Yan-Wei Lin; Hua Xiong; Ying-Xuan Chen; Jie Xu; Jing-Yuan Fang

doi:10.18632/oncotarget.14163

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Research Papers:

CD44v6 overexpression related to metastasis and poor prognosis of colorectal cancer: A meta-analysis

Ji-Lin Wang _, Wen-Yu Su, Yan-Wei Lin, Hua Xiong, Ying-Xuan Chen, Jie Xu and Jing-Yuan Fang

PDF | HTML | How to cite

Oncotarget. 2017; 8:12866-12876. https://doi.org/10.18632/oncotarget.14163

Metrics: PDF 1825 views | HTML 2801 views | ?

Abstract

Ji-Lin Wang1,*, Wen-Yu Su1,*, Yan-Wei Lin2, Hua Xiong1, Ying-Xuan Chen1, Jie Xu1, Jing-Yuan Fang1

1Division of Gastroenterology and Hepatology, Key Laboratory of Gastroenterology and Hepatology, Ministry of Health, State Key Laboratory for Oncogenes and Related Genes, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai Institute of Digestive Disease, Shanghai 200001, China

2Department of Rheumatology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200001, China

*These authors have contributed equally to this work

Correspondence to:

Ji-Lin Wang, email: [email protected]

Jie Xu, email: [email protected]

Jing-Yuan Fang, email: [email protected]

Keywords: CD44v6, prognosis, colorectal cancer, meta-analysis

Received: October 04, 2016 Accepted: November 24, 2016 Published: December 24, 2016

ABSTRACT

CD44v6 has recently been reported as a biomarker for colorectal cancer. However, the clinical and prognostic significance of CD44v6 in colorectal cancer remains controversial. Therefore, we performed a meta-analysis to clarify this issue. A comprehensive literature search was performed using Medline, Embase and Web of Science, and the statistical analysis was conducted using Stata software. A total of twenty-one studies including 3918 colorectal cancer cases were included. The pooled analysis showed that CD44v6 overexpression in colorectal cancer was an independent prognostic marker correlating with lower 5-year overall survival rate (OR=0.78, 95%CI =0.67-0.91, p=0.001). CD44v6 overexpression was also associated with more lymph node invasion (OR=1.48, 95%CI= 1.02-2.15, p=0.04), and advanced Dukes stage (OR=2.47, 95%CI= 1.29-4.73, p=0.01). In addition, while excluding Zolbec’s study, CD44v6 overexpression was associated with distance metastasis (OR=1.65, 95%CI =1.13-2.40, p=0.01). Taken together, this meta-analysis suggested that CD44v6 is an efficient prognostic factor in colorectal cancer.

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 14163

Publication Alerts

Research Papers:

CD44v6 overexpression related to metastasis and poor prognosis of colorectal cancer: A meta-analysis

Abstract